ABC-08, A phase 1b multi-centre, open-label study of a first-in-class nucleotide analogue Acelarin (NUC-1031) in combination with cisplatin in patients with locally advanced/metastatic biliary tract cancers

Project Details

Short titleP:KBF ABC-08, A phase 1b
Effective start/end date23/12/1531/03/20


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.